EVerZom

About:

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.

Website: https://www.everzom.com/

Top Investors: European Innovation Council

Description:

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles. They develop a bioproduction platform to produce extracellular vesicles at a commercial scale in a GMP compliant way for pharmaceutical companies with applications in regenerative medicine and drug delivery. Extracellular vesicles that encompass exosomes, microvesicles, and apoptotic bodies are the tools used by cells to communicate with each other. EVerZom was founded in 2019 and is headquartered in Paris, Ile-de-France, France.

Total Funding Amount:

2.87M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paris, Ile-de-France, France

Founded Date:

2019-09-01

Contact Email:

nicolas.rousseau(AT)everzom.com

Founders:

Jeanne Volatron

Number of Employees:

1-10

Last Funding Date:

2021-11-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai